ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
3,2,Multimorbidity,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
3,3,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
4,2,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4,3,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
4,4,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5,1,Complication associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
5,2,Prostatic obstruction,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
5,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
6,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
7,1,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
7,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
8,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
8,3,Resuscitation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
9,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9,3,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
10,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
11,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
12,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
13,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,Y
14,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
15,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
15,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
16,1,Gaze palsy,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
16,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
16,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
16,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
16,5,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
17,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
